Rheumatoid Arthritis and Hair Loss: Causes and Remedies – Everyday Health
One study found that 3.3 percent of the women with rheumatic diseases including RA who took the anti-TNF therapies etanercept […]
Google News
Preview of RheumNow Live 2026
Preview of RheumNow Live 2026 tammytilley@gm… Tue, 12/09/2025 – 17:55 Education/ACR/EULAR General Rheumatology Drs. Jack Cush and Artie Kavanaugh preview
RheumNow
B Cell Targeting in Idiopathic Thrombocytopenic Purpura
B Cell Targeting in Idiopathic Thrombocytopenic Purpura jjcush@gmail.com Tue, 12/09/2025 – 17:50
RheumNow
I Can’t Believe it’s Not Seronegative Rheumatoid Arthritis?!
I Can’t Believe it’s Not Seronegative Rheumatoid Arthritis?! daricmueller@g… Tue, 12/09/2025 – 17:50
RheumNow
APPs in the news (12.5.2025) Dr. Jack Cush reviews the news and journal reports from https://t.co/V10S4oVFsv, includin
APPs in the news (12.5.2025) Dr. Jack Cush reviews the news and journal reports from https://t.co/V10S4oVFsv, includin https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue,
Google News
Oral Glucocorticoid Treatment for Checkpoint Inhibitor Associated Inflammatory Arthritis … – EMJ
Rheumatologists often prescribe glucocorticoids at lower doses than oncology guidelines recommend. These findings suggest that glucocorticoid …
Google News
The Evolving Digital Landscape of Social Media among Rheumatology Professionals – EMJ
1. Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, UK; 2. School of Infection, Inflammation and Immunology, …
PubMed
Metal Hypersensitivity-Related Refractory Coronary In-Stent Restenosis Treated With Prednisone and Dupilumab: A Case Report
J Investig Allergol Clin Immunol. 2025 Dec 9:0. doi: 10.18176/jiaci.1131. Online ahead of print. NO ABSTRACT PMID:41364385 | DOI:10.18176/jiaci.1131
PubMed
Review no. 1: designing clinical kidney research using real-world data: research questions, data sources, and analytical skills
Clin Exp Nephrol. 2025 Dec 9. doi: 10.1007/s10157-025-02789-3. Online ahead of print. ABSTRACT This review series provided methodological guidance for
PubMed
Evaluation of a rural telerheumatology service in the Gilgit-Baltistan region of Pakistan: patient and physician experience
Clin Rheumatol. 2025 Dec 9. doi: 10.1007/s10067-025-07871-5. Online ahead of print. ABSTRACT Between April 2022 and April 2023, our group
PubMed
Influence of anti-tumor necrosis factor (TNF) treatments on T cell cytokine production in patients with inflammatory joint diseases – comparison of etanercept and anti-TNF monoclonal antibodies. A double-blind, prospective, placebo-controlled study
J Physiol Pharmacol. 2025 Oct;76(5):509-523. doi: 10.26402/jpp.2025.5.03. Epub 2025 Nov 28. ABSTRACT Despite similar clinical effectiveness of tumor necrosis factor
PubMed
Photon-counting CT of Bone Erosions Induced by Gouty Tophi
Radiology. 2025 Dec;317(3):e252085. doi: 10.1148/radiol.252085. NO ABSTRACT PMID:41363983 | DOI:10.1148/radiol.252085
PubMed
Delays in the Diagnosis and Treatment of Systemic Lupus Erythematosus in Latin America: A Multinational Qualitative Study From the GLADEL/PANLAR Network
J Clin Rheumatol. 2025 Dec 9. doi: 10.1097/RHU.0000000000002302. Online ahead of print. NO ABSTRACT PMID:41363890 | DOI:10.1097/RHU.0000000000002302
PubMed
Compartment-Specific NK Cell Phenotypes Reveal Distinct Maturation and Activation States in Inflammatory Arthritis
J Innate Immun. 2025;17(1):522-538. doi: 10.1159/000548548. Epub 2025 Oct 31. ABSTRACT <p>Introduction: Synovial natural killer (NK) cells contribute to inflammation
PubMed
BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
J Clin Oncol. 2025 Dec 9:JCO2502380. doi: 10.1200/JCO-25-02380. Online ahead of print. ABSTRACT PURPOSE: BRUIN CLL-313 is a randomized, open-label,
PubMed
Motor unit discharge properties of the vastii muscles and their modulation with contraction level depend on the knee-joint angle
J Appl Physiol (1985). 2025 Dec 9. doi: 10.1152/japplphysiol.00951.2024. Online ahead of print. ABSTRACT This study examined the effect of
PubMed
Response to “Refining the Interpretation of Drug Survival and Safety in VEXAS Syndrome: The Importance of Competing Risks and Exposure Time” by Pei Y. et al. and “Reinterpreting the Efficacy of IL-1 Inhibitors in VEXAS Syndrome: A Matter of Superiority or Sequencing?” by Ding Z. et al
Arthritis Rheumatol. 2025 Dec 9. doi: 10.1002/art.70011. Online ahead of print. NO ABSTRACT PMID:41363145 | DOI:10.1002/art.70011
PubMed
Distinct natural killer cell signature in still’s disease: Insights from a multinational immunome project consortium for autoinflammatory disorders
Arthritis Rheumatol. 2025 Dec 9. doi: 10.1002/art.70008. Online ahead of print. ABSTRACT OBJECTIVE: Still’s disease (SD) is a rare systemic
RheumNow
RHEUM Survey> What is the goal for every new MSK patient evaluation?
RHEUM Survey> What is the goal for every new MSK patient evaluation? https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/09/2025 – 14:12 RheumNow Dr.
Rheumatology
Q&A: Medicare PFS will benefit primary care, but budget neutrality is ‘the bigger issue’
Several changes in the 2026 Medicare Physicians Fee Schedule, or PFS, will help to better support primary, preventive and comprehensive
RheumNow
Cross-sectional study of 79 743 US primary care practices compared those with and without NPs. NP practices were more
Cross-sectional study of 79 743 US primary care practices compared those with and without NPs. NP practices were more https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
ClinicalTrials.gov
Comparison Between JAK Inhibitors and Traditional Treatment of Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis; Arthritis Interventions: Drug: JAK inhibitors and traditional treatment of rheumatoid arthritis Sponsors: Assiut University Not yet recruiting
RheumNow
QD Clinic: CAR-T Cell Therapy for Lupus Philip Mease, MD and Cayla Alexander, DNP, ARNP, Seattle, Washington, discuss
QD Clinic: CAR-T Cell Therapy for Lupus Philip Mease, MD and Cayla Alexander, DNP, ARNP, Seattle, Washington, discuss https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
DMARD Treatment Lags for Minority Groups with Rheumatoid Arthritis Use of disease-modifying anti-rheumatic drugs (DMARD
DMARD Treatment Lags for Minority Groups with Rheumatoid Arthritis Use of disease-modifying anti-rheumatic drugs (DMARD https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/09/2025 –
Google News
Photon-counting CT of Bone Erosions Induced by Gouty Tophi | Radiology – RSNA Journals
A 62-year-old man with gout was referred to the rheumatology department of our institution. His first flares occurred approximately 20
Rheumatology
The emerging role of GLP-1s in inflammatory diseases
About one in eight adults say they are taking a GLP-1 receptor agonist as a treatment for obesity, diabetes or
The Rheumatologist
EU Recommends Approval of Anifrolumab Auto-Injector
Research demonstrating the effectiveness of subcutaneous anifrolumab-fnia as an auto-injector in patients with active systemic lupus erythematosus is the basis